Success Metrics

Active Trials
1(25%)

Phase Distribution

Ph phase_1
1
25%
Ph phase_4
1
25%
Ph phase_3
1
25%
Ph not_applicable
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Other(1)

Detailed Status

Not yet recruiting2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 11 (25.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

not_yet_recruiting250%
recruiting125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Evaluation of Probiotics' Effect on Atrial Fibrillation Recurrence in Patients Undergoing Cardioversion

NCT07568964
recruitingphase_3

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

NCT05591118
not_yet_recruitingphase_4

Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes

NCT07383155
unknownphase_1

Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs

NCT04461925

Clinical Trials (4)

Showing 4 of 4 trials
NCT07568964Not Applicable

Evaluation of Probiotics' Effect on Atrial Fibrillation Recurrence in Patients Undergoing Cardioversion

Not Yet Recruiting
NCT05591118Phase 3

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

Recruiting
NCT07383155Phase 4

Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes

Not Yet Recruiting
NCT04461925Phase 1

Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4